Uluru Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
370.60
863.90
935.70
442.60
717.20
Cost of Goods Sold (COGS) incl. D&A
942.00
1,224.50
933.20
962.10
737.10
Gross Income
571.40
360.60
2.50
519.50
19.90
SG&A Expense
2,076.30
2,544.10
2,444.20
1,754.20
1,718.00
EBIT
2,647.70
2,904.70
2,441.70
2,273.70
1,737.90
Unusual Expense
-
1,064.90
-
2,027.30
228.30
Non Operating Income/Expense
3.60
53.90
79.70
8.40
5.50
Interest Expense
506.50
50.60
178.90
161.90
421.30
Pretax Income
3,080.90
1,938.80
2,700.00
4,453.60
1,936.30
Consolidated Net Income
3,080.90
1,938.80
2,700.00
4,453.60
1,936.30
Net Income
3,080.90
1,938.80
2,700.00
4,453.60
1,936.30
Net Income After Extraordinaries
3,080.90
1,938.80
2,700.00
4,453.60
1,936.30
Net Income Available to Common
3,111.20
1,938.80
2,700.00
4,453.60
1,936.30
EPS (Basic)
0.21
0.08
0.10
0.08
0.02
Basic Shares Outstanding
14,772.60
23,639.40
25,899.20
56,680.10
125,485.40
EPS (Diluted)
0.21
0.08
0.10
0.08
0.02
Diluted Shares Outstanding
14,772.60
23,639.40
25,899.20
56,680.10
125,485.40
EBITDA
1,927.90
2,192.20
1,779.80
1,339.30
1,230.50
Non-Operating Interest Income
69.70
5.40
0.30
0.80
0.00
Preferred Dividends
30.20
-
-
-
-

About Uluru

View Profile
Address
4410 Beltway Drive
Addison Texas 75001
United States
Employees -
Website http://www.uluruinc.com
Updated 07/08/2019
ULURU Inc. is a pharmaceutical company, which engages in the development and commercialization of wound care and muco-adhesive film products. It operates through Nanoflex Technology: Altrazeal and Transmucosal Drug Delivery: OraDisc. The company was founded in 1987 and is headquartered in Addison, TX.